Emerging peptide therapeutics, monoclonal antibodies, precision medicines and novel delivery technologies are expanding what’s possible in veterinary medicine. At the same time, evolving regulatory expectations and increasingly complex analytical requirements are raising the bar for bioanalysis.
Animal health innovation deserves the same scientific rigor, analytical capabilities and quality standards as human drug development. From companion animals to livestock, veterinary medicines improve health, food security and quality of life worldwide.
As these programs become more sophisticated, sponsors need scientific partners with the analytical capabilities, quality systems and regulatory understanding to help
move promising therapies forward. Veloxity brings LC-MS expertise, quality-focused study execution and experience across complex therapeutics to support animal health sponsors throughout development.
Transitioning to the ICH M10 Bioanalytical Guidance
Learn how evolving regulatory expectations are shaping veterinary bioanalysis and how ICH M10 guidance can inform animal health studies.
Quality isn’t something inspected at the end of a study.
Explore six quality disciplines that can reduce rework, improve predictability and strengthen inspection readiness.
Quantitation for Peptides and GLP-1 Bioanalysis
See early performance data from the SCIEX ZenoTOF 8600 for peptide and GLP-1 bioanalysis, including sensitivity findings relevant to complex therapeutics.
Learn how researchers developed and validated a robust HPLC-MS/MS assay for semaglutide in human plasma, creating a reliable method for clinical bioanalysis and future GLP-1 therapeutics. Read the full publication for the complete findings.
Bioanalytical approaches tailored to veterinary therapeutics, species, matrices and study needs.
Small molecules, peptides, proteins and complex biologics.
Quality-focused processes designed to support reliable data, traceability and inspection readiness.
Rapid study initiation with responsive scientific collaboration.
Whether you’re evaluating a complex therapeutic, developing a new formulation or route of administration, or preparing for regulated bioanalysis, talk with our team about the analytical needs of your next animal health study.
